Latest stories on SLS
SLS Stock Gets A BlackRock Spotlight Ahead Of Phase 3 AML Data — Bulls Spot 2027 European GPS Approval Forecast
Stocktwits News64 · neutralanalyst
Sellas Life Sciences: Too Many Survivors For Its Own Trial Plan
Seeking Alpha38 · neutralgeneral
SLS Stock Jumps Overnight: Retail Eyes Huge Potential Buyout As CEO Marks 15 Years
Stocktwits News64 · neutralgeneral
SLS Stock Climbs Pre-Market: CEO's Early Anniversary Post Has Retail Bulls Buzzing About Major News
Stocktwits News63 · neutralgeneral
Why Are Nasdaq Futures Soaring Premarket? NBIS, MU, TSLA, SPCX, ASTS, SLS Stocks In Focus
Stocktwits News64 · neutralgeneral
SLS Stock Logs Worst Week In Over A Month: Retail Bulls Bet ASH Embargo Is Keeping Regal Results Under Wraps
Stocktwits News58 · neutralgeneral
Sellas Life Sciences falls -13.1%
The Fly34 · bearishgeneral
Sellas Life Sciences falls -12.5%
The Fly34 · bearishgeneral
SLS, IBRX Rise Premarket: Funds Raise Their Bets As J&J Stays ‘On The Lookout’ For Deals
Stocktwits News64 · neutralm&a
Dow, S&P 500, Nasdaq Futures Mixed Amid Rising Oil Prices Ahead Of CPI Data: BAC, RIVN, SLS, GME Stocks In Focus
Stocktwits News50 · neutralmacro
Why Are Nasdaq Futures Rising Premarket? MU, IREN, SLS, NIO, ASTS, WFF Stocks In Focus
Stocktwits News58 · neutralgeneral
SLS Stock Jumps Overnight: Retail Sees Big Pharma Buyout Clues In 'M&A Negotiation Lounge' Booth At ASH
Stocktwits News64 · neutralm&a
SLS Stock’s 2-Week Rally Loses Steam: Retail Sees ‘Peanut Prices’ As Fresh AML Study Fuels Regal Hopes
Stocktwits News63 · neutralproduct/pr
Sellas Life Sciences put volume heavy and directionally bearish
The Fly34 · bearishgeneral
SLS Stock Snaps 3-Quarter Winning Streak — Retail Traders Speculate On Buyout, Eye Lease Through 2027
Stocktwits News54 · neutralgeneral
Biotech Lagged The Broader Market In September — Did Retail Favorites SLS, IBRX, VNDA And IOVA Dodge XBI’s Slump?
Stocktwits News53 · neutralgeneral
SLS009 showed 17.9% apoptosis vs 2.8% for daraxonrasib in a resistant pancreatic cancer model, SELLAS says
MarketChameleon63 · neutralproduct/pr
SLS Stock Slips 3% As Pancreatic Cancer Lab Data Leave REGAL Wait Unanswered
Stocktwits News38 · neutralgeneral
Sellas Life Sciences presents preclinical data on SLS009 at AACR Conference
The Fly63 · neutralproduct/pr
SLS Stock Slips Overnight Ahead Of Pancreatic Cancer Conference — Retail Looks For Clues To SLS009’s Next Trial
Stocktwits News42 · neutralproduct/pr
Sellas Life Sciences: Valued For Perfection, REGAL Trial Success Probability Priced In
Seeking Alpha56 · neutralanalyst
SLS Draws Investor Lawsuit Scrutiny After Phase 3 GPS Trial Timing Questions
September 18, 2026
MarketChameleon34 · bearishgeneral